Barclays analyst Karen Short maintains Target (NYSE:TGT) with a Overweight and raises the price target from $225 to $260.
Bristol-Myers Squibb: Q4 Earnings Insights
Bristol-Myers Squibb (NYSE:BMY) reported its Q4 earnings results on Friday, February 4, 2022 at 06:59 AM.
Here's what investors need to know about the announcement.